Back to Research

Organization profile

Luciole Medical

Luciole Medical is a Swiss medtech company that develops next-generation brain monitoring technologies for use in neurocritical care and anesthesia. Utilizing proprietary near-infrared spectroscopy (NIRS) and advanced analytics, the company provides real-time data on cerebral blood flow and oxygenation to prevent secondary brain injury in high-risk patients.

Zurich, SwitzerlandFounded 2007

Overview

1. Executive Summary (Confidence: High)

Luciole Medical has established a first-mover position in the brain monitoring market with a platform that measures critical brain function parameters across a broad range of hospital settings. Headquartered in Zurich, the company is unique in having obtained market approval (CE-mark) for both its non-invasive adhesive patch and its intracranial probe. In June 2023, Luciole significantly expanded its market presence and manufacturing capacity by acquiring Spiegelberg GmbH & Co. KG, a specialized German provider of neurosurgical equipment. With a leadership team of seasoned MedTech executives, Luciole is transforming brain monitoring by establishing cerebral blood flow (CBF) and oxygenation as "vital signs" for better patient care.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.